U.S. Bioprocess Containers Market Will Grow Rapidly In Coming Years

U.S. Bioprocess Containers Market Summary

The U.S. bioprocess containers market size was estimated at USD 1.09 billion in 2024 and is projected to reach USD 6.55 billion by 2033, expanding at a compound annual growth rate (CAGR) of 22.1% from 2025 to 2033. This significant growth is primarily fueled by the increasing adoption of single-use technologies in biopharmaceutical manufacturing. The demand for flexible, scalable, and cost-effective solutions in biologics and vaccine production continues to rise, as manufacturers look to optimize efficiency and minimize contamination risks. These containers offer adaptability and streamline biomanufacturing operations, aligning with the industry's ongoing transition toward more agile production systems.

Moreover, the market is further accelerated by strong investments in research and development as well as the presence of supportive regulatory frameworks that encourage innovation and product adoption. The rapid expansion of the biopharmaceutical sector, especially in areas such as monoclonal antibodies, cell and gene therapies, and vaccines, has elevated the demand for efficient and hygienic processing equipment. Single-use bioprocess containers (SUBCs) are increasingly favored over traditional stainless-steel systems due to their lower maintenance requirements, enhanced sterility assurance, and ability to support accelerated production timelines without compromising product integrity.

Key Market Trends & Insights

• A notable example is the surge in mRNA vaccine production during the COVID-19 pandemic, which emphasized the critical role of scalable and disposable bioprocessing solutions. Leading pharmaceutical companies like Pfizer and Moderna relied extensively on single-use technologies to expedite development and manufacturing, demonstrating their effectiveness in large-scale, time-sensitive projects. This trend has since continued post-pandemic, reinforcing the long-term value of SUBCs in modern biomanufacturing processes that require rapid deployment and flexibility.
• By product type, the 3D bioprocess containers segment is projected to grow at a strong CAGR of 23.1% from 2025 to 2033 in terms of revenue. These containers are specifically designed for large-volume handling and provide enhanced fluid management capabilities, making them a preferred choice for bulk drug production and large-scale upstream processes. Their ease of use and integration with automated systems further support operational efficiency and scalability.
• By application, the upstream processes segment is also forecasted to grow at a considerable CAGR of 22.9% from 2025 to 2033. The use of bioprocess containers in cell culture, fermentation, and media preparation continues to increase due to their ability to maintain product sterility while accommodating diverse process requirements. The growing need for higher productivity and faster turnaround times in biologics manufacturing is directly influencing the uptake of single-use systems in upstream bioprocessing.
• By end use, the contract research organizations (CROs) and contract manufacturing organizations (CMOs) segment is expected to witness substantial growth, with a projected CAGR of 22.9% from 2025 to 2033. These organizations are integral to the biopharma supply chain, often adopting single-use systems to achieve faster project delivery, minimize cleaning validation requirements, and reduce overall production costs. Their increasing presence in the market supports further growth of bioprocess container usage across outsourced service providers.

Order a free sample PDF of the U.S. Bioprocess Containers Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 1.09 Billion
• 2033 Projected Market Size: USD 6.55 Billion
• CAGR (2025-2033): 22.1%

Key Companies & Market Share Insights

Key players operating in the U.S. bioprocess containers market are undertaking various initiatives to strengthen their presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are key in propelling the market growth.

Key Players

• Thermo Fisher Scientific Inc.
• Merck
• Saint-Gobain
• Parker Hannifin Corp
• Kiefel
• Sartorius AG
• CellBios
• Entegris
• Liquidyne Process Technologies, Inc.
• Vonco Products, LLC
• Anlagenbau GmbH
• Avantor, Inc.
• ILC Dover

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

In conclusion, the U.S. bioprocess containers market is set for robust growth, driven by the rising demand for efficient, scalable, and contamination-free manufacturing solutions in biopharmaceutical production. Strong R&D investment, favorable regulations, and increasing reliance on single-use technologies across CROs, CMOs, and upstream applications underscore this trend. The market’s growth is also reinforced by high adoption in mRNA vaccine production and other advanced therapies, reflecting a shift towards flexibility and rapid scale-up. With 3D bioprocess containers and upstream processing leading in growth, the market is poised to play a pivotal role in the evolving landscape of modern biomanufacturing.